A clinical study on siddha trail drug karanthai chooranan (Int) and karappan ennai (Ext) in patients having eczema

An open comparative clinical evalvation on karappan (eczema)with traditional siddha formulation karanthai chooranan (Int) and karappan ennai (Ext)

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/05/013617

Enrollment

Registered

2018-05-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Karapan (Eczema)

Interventions

Intervention1: Karanthai chooranan (Internal)and karapan ennai (External): 10 grams of karanthai chooranan twice daily for 48 days and karapan ennai for 48 days as external medicine Intervention2:

Eligibility

Inclusion criteria

Inclusion criteria: Itching,Erythema,Papule,Macule,Pustules,Vesicules,Oozing ,Crusting,Scaling Lichenification

Exclusion criteria

Exclusion criteria: Solardermatitis,Cardiovascular diseases, any skin disease other than eczema,Pregnant women and lactating mother,auto immune disorder,Diabetes mellitus,secondary infection,HIV +ve

Design outcomes

Primary

Measure	Time frame
Reduction in clinical symptoms like( itching, scaling ,vesicle, oozing and Lichenification). Reduction in EASI Score (Eczema area severity index)Timepoint: nil	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr M Mohammed Mustafa

Govt siddha medical college, chennai

profmustafahod@gmail.com9444190077

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026